Association of FEF25%–75% and bronchodilator reversibility with asthma control and asthma morbidity in inner-city children with asthma

Watcharoot Kanchongkittiphon; Jonathan M. Gaffin; Lianne Kopel; Carter R. Petty; Mary E. Bollinger; Rachel L. Miller; Matthew Perzanowski; Elizabeth C. Matsui; Wanda Phipatanakul

doi:10.1016/j.anai.2016.04.029

Association of FEF_25%–75% and bronchodilator reversibility with asthma control and asthma morbidity in inner-city children with asthma

Watcharoot Kanchongkittiphon
, Jonathan M. Gaffin
, Lianne Kopel
, Carter R. Petty
, Mary E. Bollinger
, Rachel L. Miller
, Matthew Perzanowski
, Elizabeth C. Matsui
, Wanda Phipatanakul

Research output: Contribution to journal › Article › peer-review

17 Scopus citations

Original language	English
Pages (from-to)	97-99
Number of pages	3
Journal	Annals of Allergy, Asthma and Immunology
Volume	117
Issue number	1
DOIs	https://doi.org/10.1016/j.anai.2016.04.029
State	Published - Jul 2016
Externally published	Yes

Access to Document

10.1016/j.anai.2016.04.029

Cite this

Kanchongkittiphon, W., Gaffin, J. M., Kopel, L., Petty, C. R., Bollinger, M. E., Miller, R. L., Perzanowski, M., Matsui, E. C., & Phipatanakul, W. (2016). Association of FEF_25%–75% and bronchodilator reversibility with asthma control and asthma morbidity in inner-city children with asthma. Annals of Allergy, Asthma and Immunology, 117(1), 97-99. https://doi.org/10.1016/j.anai.2016.04.029

@article{63e210d6ba0540a39931640a6e20528c,

title = "Association of FEF25\%–75\% and bronchodilator reversibility with asthma control and asthma morbidity in inner-city children with asthma",

author = "Watcharoot Kanchongkittiphon and Gaffin, \{Jonathan M.\} and Lianne Kopel and Petty, \{Carter R.\} and Bollinger, \{Mary E.\} and Miller, \{Rachel L.\} and Matthew Perzanowski and Matsui, \{Elizabeth C.\} and Wanda Phipatanakul",

note = "Funding Information: Funding Sources: This study was supported by grants R01 AI 073964, K24 AI 106822, K24 AI 114769, K23 AI 106945, U01 AI 110397, U01 Al 083238, and P30 ES009089 from the National Institutes of Health. This work was conducted with support from Harvard Catalyst | The Harvard Clinical and Translational Science Center, National Center for Research Resources and the National Center for Advancing Translational Sciences, National Institutes of Health Award UL1 TR001102, and financial contributions from Harvard University and its affiliated academic healthcare centers. Letter ",

year = "2016",

month = jul,

doi = "10.1016/j.anai.2016.04.029",

language = "English",

volume = "117",

pages = "97--99",

journal = "Annals of Allergy, Asthma and Immunology",

issn = "1081-1206",

publisher = "American College of Allergy, Asthma and Immunology",

number = "1",

}

Kanchongkittiphon, W, Gaffin, JM, Kopel, L, Petty, CR, Bollinger, ME, Miller, RL, Perzanowski, M, Matsui, EC & Phipatanakul, W 2016, 'Association of FEF_25%–75% and bronchodilator reversibility with asthma control and asthma morbidity in inner-city children with asthma', Annals of Allergy, Asthma and Immunology, vol. 117, no. 1, pp. 97-99. https://doi.org/10.1016/j.anai.2016.04.029

TY - JOUR

T1 - Association of FEF25%–75% and bronchodilator reversibility with asthma control and asthma morbidity in inner-city children with asthma

AU - Kanchongkittiphon, Watcharoot

AU - Gaffin, Jonathan M.

AU - Kopel, Lianne

AU - Petty, Carter R.

AU - Bollinger, Mary E.

AU - Miller, Rachel L.

AU - Perzanowski, Matthew

AU - Matsui, Elizabeth C.

AU - Phipatanakul, Wanda

N1 - Funding Information: Funding Sources: This study was supported by grants R01 AI 073964, K24 AI 106822, K24 AI 114769, K23 AI 106945, U01 AI 110397, U01 Al 083238, and P30 ES009089 from the National Institutes of Health. This work was conducted with support from Harvard Catalyst | The Harvard Clinical and Translational Science Center, National Center for Research Resources and the National Center for Advancing Translational Sciences, National Institutes of Health Award UL1 TR001102, and financial contributions from Harvard University and its affiliated academic healthcare centers. Letter

PY - 2016/7

Y1 - 2016/7

UR - https://www.scopus.com/pages/publications/84970002317

U2 - 10.1016/j.anai.2016.04.029

DO - 10.1016/j.anai.2016.04.029

M3 - Article

C2 - 27236218

AN - SCOPUS:84970002317

SN - 1081-1206

VL - 117

SP - 97

EP - 99

JO - Annals of Allergy, Asthma and Immunology

JF - Annals of Allergy, Asthma and Immunology

IS - 1

ER -